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Abstract: The ATP binding cassette containing transporters are a superfamily of integral membrane proteins that 
translocate a wide range of substrates. The subfamily B members include the biologically important multidrug resis-
tant (MDR) protein and the transporter associated with antigen processing (TAP) complex. Substrates translocated 
by this subfamily include drugs, lipids, peptides and iron. We have constructed a comprehensive set of comparative 
models for the transporters from eukaryotes and used these to study the effects of sequence divergence on the sub-
strate translocation pathway. Notably, there is very little structural divergence between the bacterial template struc-
ture and the more distantly related eukaryotic proteins illustrating a need to conserve transporter structure. By 
contrast different properties have been adopted for the translocation pathway depending on the substrate type. A greater 
level of divergence in electrostatic properties is seen with transporters that have a broad substrate range both within 
and between species, while a high level of conservation is observed when the substrate range is narrow. This study 
represents the first effort towards understanding effect of evolution on subfamily B ABC transporters in the context 
of protein structure and biophysical properties.
Abbreviations: A. thaliana, Arabidopsis thaliana; D. melanogaster, Drosophilia melanogaster; S. aureus, 
Staphylococcus aureus; ABC, ATP binding cassette; TAP, Transporter associated with antigen processing.
Keywords: comparative modelling, ABC transporter, structure, electrostatic potential
Introduction
The ATP-binding cassette (ABC) superfamily of transporters translocate a wide range of compounds 
across cellular membranes using the energy released through ATP hydrolysis. They are integral membrane 
proteins that have an all helical transmembrane domain (TMD) consisting of between 6 and 11 helices 
and an intracellular domain containing the ATP-binding cassette (nucleotide binding domain, NBD). 
The NBD has a Walker A and Walker B motif separated by the ABC signature, LSGGQ. These proteins 
have a common domain arrangement of two TMDs and two NBDs and are either produced as a single 
polypeptide (full transporter) or as half transporters containing one NBD and one TMD (for reviews 
see (Davidson and Chen, 2004; Dean and Annilo, 2005)).
Multiple ABC transporter genes exist in the genomes of bacteria and eukaryotes (Saurin et al. 1999) 
and, in humans, there are 48 genes divided into 8 subfamilies based on sequence analysis of the NBDs 
(Dean and Annilo, 2005). Loss of function mutations are associated with complex diseases that include 
Cystic Fibrosis, various retinal degeneration disorders and a number of liver conditions (Dean, 2005; 
Klein et al. 1999), while transporter overexpression and increased effl ux activity is associated with the 
development of drug-resistance in cancers (Chen et al. 1986; McDevitt and Callaghan, 2007; Riordan 
and Ling, 1985; Roninson et al. 1986). Increased transporter activity may also be involved in the devel-
opment of a multi-drug resistance phenotype in bacteria and other pathogenic organisms (van Veen 
et al. 1998; van Veen et al. 1996).
The ABC subfamily B consists of full and half transporters that have a diverse range of biological 
roles. Members of the subfamily include MDR1, initially identifi ed in drug-resistant cancer cell lines 
(Chen et al. 1986; Juliano and Ling, 1976), and TAP, the heterodimeric peptide transporter involved in 
the formation of the major histocompatibility complex. Interestingly, mutations in the TAP1 and TAP2 
genes, although rare (de la Salle et al. 1999), give rise to immunodefi ciency disorders. Other members 
have roles in translocation of iron, lipids and bile salts.
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Recently, the fi rst complete and functionally 
relevant structure of a homodimeric subfamily 
B member, Sav1866, from the bacterium S. aureus, 
was reported (Dawson and Locher, 2006). Within 
the NBD, the Walker A and B, P-loop and ABC 
signature motifs overlay closely with NBDs of 
other bacterial transporters indicating structural 
conservation around the ATP binding site. Signifi -
cantly, this structure illustrates the presence of a 
cavity at the interface of the two transmembrane 
subunits that is closed at the NBD end, and likely 
to be located in the cytoplasm, while an open con-
formation is adopted at the opposite end, proposed 
to be in the extracellular space. Residues associated 
with substrate binding in MDR map to this cavity 
further supporting its potential as the translocation 
pathway (Loo and Clarke, 2001; Loo and Clarke, 
2002; Maki et al. 2006). Similar cavities are 
observed in crystal structures of other membrane 
transporters (Dawson and Locher, 2006; Pinkett 
et al. 2007). To maximise the effect of this structure 
in understanding the evolution of function within 
the ABC subfamily B, we have clustered subfam-
ily members based on comparison of full length 
sequences, and used the alignment to compara-
tively model representative members. These mod-
els provide a structural context within which 
sequence divergence and effects on substrate 
specifi cities of this subfamily can be interpreted.
Methods
Sequence identifi cation and selection
A total of 116 amino acid sequences including the 
eukaryotic ABC transporter subfamily B and 
bacterial orthologs of the Sav1886 protein from 
S. aureus were used in this analysis. Eukaryotic 
sequences were downloaded from the National 
Center for Biotechnology Information’s Homolo-
gene database (www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=homologene). Clusters of homolo-
gous protein sequences for all 12 members of the 
ABC subfamily B were obtained (Homologene 
cluster identifi ers are: tap1(B2), 495; tap2(B3), 
37323; B1a, 55496; B1b, 69084; B4, 56421; B5, 
83488; B6, 83488; B7, 3175; B8, 5203; B9, 10491; 
B10, 6474; B11, 74509.
Bacterial orthologs of Sav1886 were identifi ed 
in the IMG database (http://img.jgi.doe.gov/) 
(Markowitz et al. 2006) of pre-computed clusters of 
best pair-wise BLAST alignments (ortholog cluster 
7683, 37 sequences). The sequence of Sav1866 was 
included in the bacterial set as a reference.
Sequence alignment, clustering
and model generation and analysis
Sequence alignment and structural comparison of 
gene products within the subfamily B of ABC 
transporters is a complex problem that has neces-
sitated some approximations. The most signifi cant 
of these, is the alignment of single polypeptides 
that form a functional full transporter against 
single polypeptides that form half transporter units 
that are only functional as dimers. To address this, 
the half transporter sequences were duplicated 
to represent a “pseudo-full-transporter” which 
allowed comprehensive alignment over the full 
transporter sequences. As there is substantial 
sequence difference between eukaryotic and bacte-
rial ABC transporter sequences, the multiple 
sequence alignment was constructed in two phases. 
Initially, separate multiple sequence alignments 
were computed for eukaryotes and bacteria, 102 
and 14 sequence sets respectively. The alignments 
were then combined using a profi le approach to 
avoid misalignment resulting from the construction 
of pseudo-full-transporter sequence. Due to its 
effi ciency with this sized data set, the guide tree 
directed neighbour joining method as imple-
mented in CLUSTALW (Thompson et al. 1994) 
was employed, followed by the profi les method. 
The profi le alignment method relies more on con-
servation of amino acid properties rather than the 
specifi c residue and is well suited to the alignment 
of regions with remote homology, such as the 
transmembrane helices. In the absence of experi-
mentally derived structural information to validate 
the resulting multiple sequence alignment, conser-
vation of functional residues that occupy function-
ally equivalent positions in the model structures, 
such as the well-known Walker A and B motifs in 
the NBD, were used for quality assessment of the 
alignment. Conservation of these regions was 
observed between each NBD of the full transport-
ers and the half transporter units represented as 
pseudo-full-transporters. As the transmembrane 
domains have no equivalent anchor points, the 
alignment through this region was assessed by 
superposition of gap sites on the template structure. 
It was clear that all gaps were located outside the 
helical regions in the template structure, illustrating 
that the conservation of residue properties across 
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the transmembrane domain between the eukarotic 
and prokaryotic sequences in this study is strong 
even though sequence identity is low. Sequences 
were clustered using the neighbour joining method 
of CLUSTALW with 100 bootstrapped replica-
tions, and the results visualised using TREEVIEW 
(Page, 1996) and used to aid the interpretation of 
biophysical properties.
Atomic models were computed using MOD-
ELLER8.2 (Fiser and Sali, 2003) with default 
settings. The structure of Sav1866 (PDB 2HYD) 
was used as the template, and pairwise alignments 
between the template and target sequences were 
extracted from the multiple sequence alignment. 
Half transporters were modelled as homodimers 
in analogy to the template structure, with exception 
of the TAP complex which was modelled as a 
heterodimer of the B2 and B3 gene products. Full 
transporters were modelled in the absence of the 
interconnecting loop between the two half trans-
porter units. A ten model ensemble was computed 
for each transporter and the best scoring model, 
determined by the lowest MODELLER objective 
function value, was used for further analysis.
Electrostatic surfaces were generated by 
solving the non-linear Poisson-Boltzmann equa-
tion using the APBS package (Baker et al. 2001) 
and visualised within PyMol (DeLano, 2002). 
APBS was used with default settings and bound-
ary conditions except the charge disc and surface 
calculation method options of multiple DH 
spheres, cubic b-spline and cubic spline respec-
tively were chosen. APBS PQR input fi les were 
generated using the PDB2PQR web service 
(Dolinsky et al. 2004). The solvent accessible 
surface was coloured with a temperature spectrum 
describing electrostatic potential using a range of 
–10 to +10 kT.
All data including sequences, multiple sequence 
alignment and model coordinates for all ABC 
transporters in this study are freely available from 
our web site http://foo.maths.uq.edu.au/~huber/
ABC/abcB.html.
Results and Discussion
Clustering of gene products
of the ABC subfamily B
Evolutionary analysis of ABC transporters is an 
extremely challenging problem, with factors such 
as different architectures and differing degrees of 
sequence divergence between domains, a likely 
necessity for development of biological function, 
requiring consideration. It is further complicated 
by integration into contexts of protein structure 
and biochemical function. Table 1 lists the ABC 
subfamily B genes used in this study along with 
their architecture, while Table 2 lists the alias, 
architecture and substrate type associated with the 
human transporter gene products. Figure 1 shows 
an unrooted tree that illustrates clustering of the 
116 subfamily B sequences from eukaryotes and 
bacteria used in this study. The subfamily partitions 
into three main clusters, each with distinct substrate 
specifi cities. Cluster I contains the B1, B4 and B11 
gene products, characterised biochemically as 
drug, lipid and bile salt transporters. These are 
primarily of full transporter architecture, with the 
exception of the half transporter B5, also involved 
in drug transport. Cluster II is composed of the half 
transporters B2 (TAP1), B3 (TAP2), B8, B9 and 
B10, and are responsible for peptide translocation 
across intracellular and mitochondrial membranes. 
These isoforms appear to have evolved according 
to their subcellular localization, in that B8 and B10 
are located in the inner mitochondrial membrane 
and are clearly separated from the cellular trans-
porters B2, B3 and B9, located in ER and lyso-
somal compartments, respectively. The half 
transporters B6 and B7 form cluster III, and are 
associated with iron transport. Of these three clus-
ters, the last group is most closely related to the 
S. aureus transporter, Sav1866, for which the full 
structure was recently determined. Overall, the 
higher eukaryotes used in this study have a larger 
number of full transporters, likely the result of gene 
duplication and fusion that, along with divergence 
in amino acid sequence has allowed diversifi cation 
in functions and substrates of this gene family.
The sequence identity between Sav1866 and 
members of the eukaryotic ABC subfamily B is in 
the range 25 to 35% which constitutes a remote 
sequence relationship but allows template-based 
comparative modelling of these transporters. 
Structural models have been constructed for the 
products of all eukaryotic genes in this study 
(Table 1). The half transporters B9 (Wolters et al. 
2005), B10 (Galluhn and Langer, 2004; Graf et al. 
2004), B6 (Krishnamurthy et al. 2006), B8 (Hogue 
et al. 1999) and B7 (Chloupkova et al. 2004; Csere 
et al. 1998) were modelled as homodimers based 
on experimental observations, while the TAP 
complex was modelled as a heterodimer as reported 
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by Kelly et al. (Kelly et al. 1992) with B2 and B3 
assuming symmetric positions in the complex. 
Although the quaternary state of B5 is unknown, 
it has been modelled conservatively as a homodimer 
as it is the only half transporter associated with 
drug translocation. Analysis of the alignment 
between the 11 human transporters and the distantly 
related bacterial template clearly illustrates that 
although there is much sequence divergence, the 
location of structural variability as indicated by 
insertions and deletions is outside the core of the 
protein.
Insertions and deletions were observed both in 
the extracellular and intracellular loops of the 
TMD and some minor length variations were also 
seen in the surface regions of the NDB. This 
indicates that the functional regions of the protein, 
the translocation pathway and the ATP binding 
site impose strong structural constraints on the 
evolution of these proteins. This may suggest that 
amino acid type distribution in the translocation 
Table 1. Distribution of ABC subfamily B members based on classifi cation by Homologene.
 Subfamily B member
Organism 1A 1B 2 3 4 5 6 7 8 9 10 11
Homo sapiens F - H H F H H H H H H F
Pan troglodytes F - H - F H H - H H - F
Canis familiaris F  - H - H H H H H - F
Mus musculus F F H H F H H H H H H F
Rattus norvegicus F F H H F H H H H H H -
Gallus gallus F - - - F - H H - H H -
Drosophila 
melanogaster F F - - F - H H H - H -
Caenorhabditis
 elegans F F - - F - H H H H H -
Oryza sativa
(japonica cultivar-group) F F - - F - - - - - H F
Arabidopsis thaliana F F - - F H - H - - H F
Anopheles gambiae F - - - - - H H - - H -
Magnaporthe 
grisea 70–15 F - - - - - H H - - - -
Schizosaccharomyces
 pombe 972h F - - - - - H H - - H -
Saccharomyces 
cerevisiae - - - - - - - H - - H -
Kluyveromyces lactis - - - - - - - H - - H -
Ashbya gossypii
ATCC10895 - - - - - - - H - - H -
Plasmodium 
falciparum 3D7 - - - - - - H - - - - -
Neurospora crassa 
OR74A - - - - - - H H - - - -
Abbreviations: F: Full transporter; H: Half transporter; -: no homolog.
Table 2. Classifi cation of human ABC subfamily B 
transporters, including alias, transporter architecture 
and substrate specifi cities.
Gene Alias Architec- Substrate
  ture 
ABCB1 PGY1,    
 MDR F Drug
ABCB2 TAP1 H Peptide (ER)
ABCB3 TAP2 H Peptide (ER)
ABCB4 PGY3 F PC
ABCB5  H Drug
ABCB6 MTABC3 H Fe (OM)
ABCB7 ABC7 H Fe/S cluster (IM)
ABCB8 M-ABC1 H Peptide (IM)
ABCB9 TAPL H Peptide (LY)
ABCB10 M-ABC2 H Peptide (IM)
ABCB11 SPGP F Bile salt
Abbreviations: F: Full transporter; H: Half transporter;
OM: outer mitochondrial membrane; IM: inner mitochondrial 
membrane; LY: lysosome.
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pathway and resulting surface properties are likely 
to infl uence the distinct subfamily B substrate 
selectivity.
Electrostatics of Translocation 
Pathway
To understand more the functional infl uence of 
evolution on translocation pathways of subfamily 
B transporters in higher eukaryotes, and its 
relationship to substrate specifi city, electrostatic 
potential was computed for a range of related 
sequences from different organisms, mapped to 
the solvent accessible surface of the translocation 
pathway, and interpreted within the taxonomic 
lineage described by the NCBI Taxamonic data-
base (http://www.ncbi.nlm.nih.gov/Taxonomy). 
Figure 2 is a comparative summary of these sur-
faces for the translocation pathway of representative 
human gene products.
Figure 1. Unrooted phylogenetic tree of transporter proteins in the ABC B subfamily. Biological processes have been associated with 
lineages based on the clustering of proteins with characterised proteins within them. The biological functions represented include drug/
lipid/bile salt (cluster I, yellow), peptide (cluster II, magenta) and iron (cluster III, green) transport. For clarity, overlapping labels from close 
homologous sequences were omitted.
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Human B1, well-characterised as a drug trans-
porter, has a concentrated strong positive electro-
static potential, >10kT toward the substrate 
entrance of the translocation pathway. This positive 
charge decays along the pathway, giving a more 
neutral electrostatic character closer to the sub-
strate exit site. The bile salt transporter B11 has 
similar surface properties (not shown). In com-
parison, B5, also associated with drug transport, 
has a positive electrostatic potential of >8kT cov-
ering the full length of the translocation pathway 
(not shown). In contrast to the drug transporters, 
B4, which has phosphatidyl choline as a substrate, 
has a concentrated negative electrostatic potential 
(<–8kT) that decays to neutral toward the substrate 
exit. The mouse and rat transporters display simi-
lar electrostatic properties to human B1, B4, and 
B5. Notably, the rodent B5 gene product unlike its 
human homolog, has a predominantly strong 
negative surface throughout the pathway, and a 
concentrated patch of positive potential around the 
substrate entrance site. This particular pathway 
electrostatic surface is specifi c to rodents. The more 
divergent D. melanogaster transporters have 
adopted a predominantly negative electrostatic 
potential similar to human B4. Clearly, during the 
long evolutionary period of separation between 
Protostomia and Deuterostomia that has lead to the 
insect and vertebrates included in this study, these 
transporters have evolved different electrostatic 
properties which are likely to refl ect differences in 
the substrate(s) transported. Substrate specialisa-
tion within the subfamily is also supported by a 
weak similarity in charge properties observed 
between the plant B1 a protein from A. thaliana 
and human B1 gene product.
The human TAP peptide transporter complex 
has a strip of concentrated negative surface poten-
tial that extends the length of the translocation 
pathway and decays towards neutral over the 
remainder of the surface. The rat complex is 
similar in that it has strong negative potential 
Figure 2. Comparative summary of electrostatic surfaces for the translocation pathway of representative transporters from human juxtaposed 
with examples from fl y (D. melanogaster) and plant (A. thaliana). The panels are cut away views illustrating part of the surface of the 
translocation pathway formed by the interface of two half transporter units. Electrostatic potentials from –10 to +10 kT are displayed on the 
surface; red represents areas of negative electrostatic potential and blue areas represent positive electrostatic potential.
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throughout the pathway (not shown), while the 
mouse TAP translocation pathway surface differs 
in that it has concentrated patches of strong positive 
potential at both ends, decaying to a centrally 
located band of neutral to weak negative electro-
static potential (not shown). The lysosomal peptide 
transporter B9, which is more closely related to 
the TAP gene products rather than the mitochon-
drial peptide transporters, also possesses a strong 
negative surface potential throughout the transloca-
tion pathway, a property also conserved in the 
rodent B9 gene product (not shown). In contrast, 
the inner mitochondrial membrane peptide trans-
porters, B8 and B10, have strong positive 
electrostatic potential throughout the pathway, 
which is also conserved in related proteins from 
fl y (D. melanogaster) and plant (A. thaliana) (not 
shown). This is consistent with their clustering as 
distant relatives to the B9 and TAP gene products 
(Fig. 1). Taken together, these results illustrate that, 
within this cluster of peptide transporters, the 
translocation pathway electrostatic surface proper-
ties partition with subcellular location into two 
smaller clusters consisting of B8 and B10, and B2, 
B3 and B9. This implies that mitochondrial pep-
tides require a pathway with a positive electrostatic 
surface, while those in other cellular compartments 
need a more negative surface, a property that is 
conserved across species.
The human iron transporters, B6 and B7, both 
have electrostatic potential surfaces similar to the 
human drug transporter B5 in that they have a 
positive charge throughout the translocation path-
way. This is clearly important in the biological 
function of iron transport as it has also been con-
served in the gene products from D. melanogaster 
and A. thaliana.
Conclusion
We have developed a comprehensive set of struc-
tural models for eukaryotic members of the ABC 
transporter subfamily B, and used these to better 
understand the effects of evolution on electrostatic 
properties of the translocation pathway within the 
subfamily. Comparison of these models indicates 
there are no substantial structural changes in the 
transporter core, implying evolutionary pressure 
to maintain a pathway through the lipid bilayer for 
the ATP dependent translocation of substrates. As 
the surface of the translocation pathway is 
important for substrate selection and movement, 
we analysed the electrostatic properties of a 
number of subfamily B representatives, from dif-
ferent species, covering the three clusters into 
which this subfamily partitions. In general, each 
cluster is associated with a distinct substrate class, 
which is refl ected in the different electrostatic 
potential properties adopted by the pathway 
surface. Furthermore, there is divergence of elec-
trostatic properties within the clusters between 
members within a species and between species 
likely refl ecting the range or origin of substrates 
recognised and translocated. This divergence 
is most clearly seen in the cluster of transporters 
that translocate diverse substrates such as drugs, 
lipids, bile salts, and peptides, while the more 
restricted substrate range of the iron transporters 
is refl ected in the conservation of their electrostatic 
properties. Interestingly, the electrostatic surface 
for human B1 refl ects the physico-chemical prop-
erties of substrates for this transporter, which are 
lipophilic compounds possessing a tertiary basic 
amine, giving a positive centre, while the negative 
surface of the phosphotidyl choline transporter B4 
refl ects the negative charge associated with the 
phosphate and acidic groups on its phospholipid 
substrate. This apparent mirroring of electrostatic 
properties is also observed in the iron transporters, 
in that they have a positive electrostatic surface 
and transport a positively charged substrate, this 
similarity is unexpected as is counterintuitive, but 
may indicate that iron is transported in complex. 
Furthermore, it is possible that these properties 
change along with conformational rearrangements 
associated with ATP binding.
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